FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068073140> ?p ?o ?g. }

• W2068073140 endingPage "281" @default.
• W2068073140 startingPage "276" @default.
• W2068073140 abstract "Abstract CD52 is expressed on malignant cells in lymphoplasmacytic lymphoma (LPL), including IgM-secreting Waldenström macroglobulinemia (WM). We examined the activity of alemtuzumab in 28 symptomatic LPL (27 IgM and 1 IgA) patients. The median prior number of therapies for these patients was 2 (range, 0-5) and 43% had refractory disease. Patients received alemtuzumab at 30 mg IV 3 times weekly for up to 12 weeks after test dosing, and also received hydrocortisone, acyclovir, and Bactrim or equivalent prophylaxis. Patients had a complete response (n = 1), a partial response (n = 9), or a MR (n = 11) for an overall and major response rate of 75% and 36%, respectively. Median serum Ig decreased from 3510 to 1460 mg/dL (P < .001 at best response). With a median follow-up of 64 months, the median time to progression was 14.5 months. Hematologic and infectious complications, including CMV reactivation, were more common in previously treated patients and were indirectly associated with 3 deaths. Long-term follow-up revealed late-onset autoimmune thrombocytopenia (AITP) in 4 patients at a median of 13.6 months after therapy, which contributed to 1 death. Alemtuzumab is an active therapy in patients with LPL, but short- and long-term toxicities need to be carefully weighed against other available treatment options. Late AITP is a newly recognized complication of alemtuzumab in this patient population. This study is registered at www.clinicaltrials.gov as NCT00142181." @default.
• W2068073140 created "2016-06-24" @default.
• W2068073140 creator A5026121534 @default.
• W2068073140 creator A5031106919 @default.
• W2068073140 creator A5069054551 @default.
• W2068073140 creator A5081299017 @default.
• W2068073140 creator A5085298680 @default.
• W2068073140 creator A5088343926 @default.
• W2068073140 creator A5091691031 @default.
• W2068073140 date "2011-07-14" @default.
• W2068073140 modified "2023-10-16" @default.
• W2068073140 title "Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab" @default.
• W2068073140 cites W1590344479 @default.
• W2068073140 cites W1973796458 @default.
• W2068073140 cites W1976156505 @default.
• W2068073140 cites W1996373638 @default.
• W2068073140 cites W1997253468 @default.
• W2068073140 cites W2012570443 @default.
• W2068073140 cites W2016293829 @default.
• W2068073140 cites W2019779933 @default.
• W2068073140 cites W2030892920 @default.
• W2068073140 cites W2034599010 @default.
• W2068073140 cites W2043831614 @default.
• W2068073140 cites W2060881050 @default.
• W2068073140 cites W2084177625 @default.
• W2068073140 cites W2091799186 @default.
• W2068073140 cites W2099323381 @default.
• W2068073140 cites W2109587991 @default.
• W2068073140 cites W2117291755 @default.
• W2068073140 cites W2117582823 @default.
• W2068073140 cites W2122119135 @default.
• W2068073140 cites W2129783860 @default.
• W2068073140 cites W2132155614 @default.
• W2068073140 cites W2137296394 @default.
• W2068073140 cites W2140181964 @default.
• W2068073140 cites W2143749371 @default.
• W2068073140 cites W2149103702 @default.
• W2068073140 cites W2150724746 @default.
• W2068073140 cites W2169167811 @default.
• W2068073140 cites W2469065745 @default.
• W2068073140 cites W3214976431 @default.
• W2068073140 doi "https://doi.org/10.1182/blood-2011-02-338558" @default.
• W2068073140 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3138682" @default.
• W2068073140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21566092" @default.
• W2068073140 hasPublicationYear "2011" @default.
• W2068073140 type Work @default.
• W2068073140 sameAs 2068073140 @default.
• W2068073140 citedByCount "38" @default.
• W2068073140 countsByYear W20680731402012 @default.
• W2068073140 countsByYear W20680731402013 @default.
• W2068073140 countsByYear W20680731402014 @default.
• W2068073140 countsByYear W20680731402015 @default.
• W2068073140 countsByYear W20680731402016 @default.
• W2068073140 countsByYear W20680731402017 @default.
• W2068073140 countsByYear W20680731402018 @default.
• W2068073140 countsByYear W20680731402019 @default.
• W2068073140 countsByYear W20680731402022 @default.
• W2068073140 countsByYear W20680731402023 @default.
• W2068073140 crossrefType "journal-article" @default.
• W2068073140 hasAuthorship W2068073140A5026121534 @default.
• W2068073140 hasAuthorship W2068073140A5031106919 @default.
• W2068073140 hasAuthorship W2068073140A5069054551 @default.
• W2068073140 hasAuthorship W2068073140A5081299017 @default.
• W2068073140 hasAuthorship W2068073140A5085298680 @default.
• W2068073140 hasAuthorship W2068073140A5088343926 @default.
• W2068073140 hasAuthorship W2068073140A5091691031 @default.
• W2068073140 hasBestOaLocation W20680731401 @default.
• W2068073140 hasConcept C126322002 @default.
• W2068073140 hasConcept C141071460 @default.
• W2068073140 hasConcept C203014093 @default.
• W2068073140 hasConcept C2776364478 @default.
• W2068073140 hasConcept C2776391228 @default.
• W2068073140 hasConcept C2778384904 @default.
• W2068073140 hasConcept C2779015954 @default.
• W2068073140 hasConcept C2779338263 @default.
• W2068073140 hasConcept C2780653079 @default.
• W2068073140 hasConcept C2781038049 @default.
• W2068073140 hasConcept C2908647359 @default.
• W2068073140 hasConcept C2910423619 @default.
• W2068073140 hasConcept C2911091166 @default.
• W2068073140 hasConcept C71924100 @default.
• W2068073140 hasConcept C90924648 @default.
• W2068073140 hasConcept C99454951 @default.
• W2068073140 hasConceptScore W2068073140C126322002 @default.
• W2068073140 hasConceptScore W2068073140C141071460 @default.
• W2068073140 hasConceptScore W2068073140C203014093 @default.
• W2068073140 hasConceptScore W2068073140C2776364478 @default.
• W2068073140 hasConceptScore W2068073140C2776391228 @default.
• W2068073140 hasConceptScore W2068073140C2778384904 @default.
• W2068073140 hasConceptScore W2068073140C2779015954 @default.
• W2068073140 hasConceptScore W2068073140C2779338263 @default.
• W2068073140 hasConceptScore W2068073140C2780653079 @default.
• W2068073140 hasConceptScore W2068073140C2781038049 @default.
• W2068073140 hasConceptScore W2068073140C2908647359 @default.
• W2068073140 hasConceptScore W2068073140C2910423619 @default.
• W2068073140 hasConceptScore W2068073140C2911091166 @default.
• W2068073140 hasConceptScore W2068073140C71924100 @default.
• W2068073140 hasConceptScore W2068073140C90924648 @default.

• next